FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

J&J Scraps Alzheimers Trial After Disappointing Data

Johnson & Johnson discontinues its Auτonomy Phase 2b Alzheimers study after interim data showed its experimental antibody posdinemab failed to pr...

Human Drugs

FDA Flags Misleading Promotion of Generic Ketamine Drug

FDA cites PharmaTher over alleged misleading promotional claims for its generic ketamine.

latest-news-card-1
Human Drugs

Novo Nordisks Alzheimers Hopes Face Set Back

Novo Nordisk says data from two global Phase 3 trials of semaglutide (Ozempic and Wegovy) have failed to slow clinical progression in adults with earl...

latest-news-card-1
Human Drugs

Woodcock Urges Stronger FDA Role in Updating Generic Labels

Former FDA principal deputy commissioner Janet Woodcock and policy experts from Duke University call on the agency to adopt new tools and pathways to ...

latest-news-card-1
Biologics

FDA Probes Death Associated With Takedas Adzynma

FDA investigates the death of a pediatric patient with congenital thrombotic thrombocytopenic purpura who developed neutralizing antibodies to the enz...

latest-news-card-1
Human Drugs

Sterility Failures Flagged at Indian Injectable Drug Maker

FDA investigators cite Immacule Lifesciences Private Limited, a sterile drug contract manufacturer in Himachal Pradesh, India, for extensive lapses in...

latest-news-card-1
FDA General

White House Sought Resignation of Top Makary Aide

New reporting finds that the White House recently requested the resignation of a senior aide to FDA commissioner Marty Makary, highlighting growing fr...

latest-news-card-1
Medical Devices

Intersurgical Recalls Video Laryngoscope Due to Safety

Intersurgical recalls (Class 1) its i-View Video Laryngoscope, citing serious safety risks that could potentially lead to severe injury or death.

latest-news-card-1
Human Drugs

Voucher Program Looks Like a Make-a-Deal Process: Experts

Three Harvard medical professors raise concerns over FDAs review voucher program that they say could politicize drug approvals and undermine scientifi...

latest-news-card-1
Human Drugs

FDA Posts Withdrawal Notice for Intercepts Ocaliva

FDA posts a Federal Register notice finalizing the withdrawal of Intercept Pharmaceuticals Ocaliva (obeticholic acid) from the U.S. market for treatin...